At the mRNA level of specimens, we found that SLC25A4 and SLC25A23 were, respectively, decreased in gastric cancer and colon cancer, while SLC25A7 was increased in gastric cancer, which was consistent with our bioinformatics prediction. This evidence concerns the gene SLC25A4 and gastric cancer.